Thermo Fisher Scientific has expanded its existing campus in Inchinnan, Scotland with the addition of a new £14m facility to produce dry powder media used in the production of drugs and vaccines for diseases such as influenze and dengue fever.
The product, sold by Thermo Fisher as Gibco Advanced Granulation Technology (AGT) Cell Culture Media, is a crucial cell culture raw material used to manufacture biologics, including vaccines, anti-cancer therapeutics and other life-saving drugs. Using AGT media offers biologics producers the benefits of traditional liquid media without the associated cost, storage and transportation issues. The company…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
